NVR BCR (Tasigna 150 mg)

Generic Name: nilotinib

Pill imprint NVR BCR has been identified as Tasigna 150 mg.

Tasigna is used in the treatment of chronic myelogenous leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Tasigna 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for NVR BCR (Tasigna 150 mg)

Tasigna
Generic Name:
nilotinib
Imprint:
NVR
BCR
Strength:
150 mg
Color:
Red
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Novartis Pharmaceuticals
National Drug Code (NDC):
00078-0592
Inactive Ingredients:
silicon dioxide
crospovidone
gelatin
lactose monohydrate
magnesium stearate
ferric oxide red
titanium dioxide
ferric oxide yellow

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Advanced Breast Cancer: Learn about treatments to improve quality of life. Click Here

Close
Hide
(web2)